Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04065451 · ClinicalTrials.gov registry record · Phase 4
Effect of Epinephrine on Post-polypectomy Pain
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT04065451 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 22 participants.
The verdict
NCT04065451, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
Epinephrine is widely used in endoscopic mucosal resection of large polyps to prevent post-polypectomy bleeding. No previous studies looked at increase in immediate post-polypectomy pain with the use of epinephrine.
Interventions
- DRUG Epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2021-08-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04065451
The ClinicalTrials.gov registry entry for NCT04065451 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epinephrine is the first listed.
NCT04065451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04065451 about?
NCT04065451 is a clinical study titled "Effect of Epinephrine on Post-polypectomy Pain". Epinephrine is widely used in endoscopic mucosal resection of large polyps to prevent post-polypectomy bleeding. No previous studies looked at increase in immediate post-polypectomy pain with the use of epinephrine.
What is the current status of trial NCT04065451?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2020-01-06. Estimated completion is 2021-08-17.
What interventions are being tested in trial NCT04065451?
The interventions under investigation include: Epinephrine (DRUG).
Who is sponsoring clinical trial NCT04065451?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.